Ricardo Capelo

Medicine · Health Sciences

4h-index95citations22works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(14), Histone Deacetylase Inhibitors Research(14), Retinoids in leukemia and cellular processes(6), Ferrocene Chemistry and Applications(6), RNA Interference and Gene Delivery(4)

Publications22 total

Supplementary Figure Legends from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S3 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Data from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S2 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S5 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S1 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Data from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S1 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S7 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure Legends from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S6 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S7 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S4 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S2 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S6 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S4 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S5 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Supplementary Figure S3 from 5-Lipoxygenase Is a Candidate Target for Therapeutic Management of Stem Cell–like Cells in Acute Myeloid Leukemia
2023Open Access
Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids·2017· 6 cited
Cellular analysis of the histamine H4 receptor in human myeloid cells
Biochemical Pharmacology·2016· 22 cited
page 1 of 2Next →

Frequent Co-authors

Astrid S. Kahnt(22), Dieter Steinhilber(22), Jessica Roos(19), Claudia Oancea(19), Maria Heinßmann(19), Hannelore Held(19), Estel la Buscató(19), Ewgenij Proschak(19), Elena Puccetti(19), Ingrid Fleming(19), Martin Ruthardt(19), Thorsten J. Maier(15), Dilawar Khan(14), Dilawar Khan(4), Thorsten J. Maier(4), Khalil Ali Ahmad(2), Nicolas Flamand(2), Rolf Marschalek(2), Dilawar Khan(1), Christoph Lehmann(1)